---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-24-005928"
form_type: "8-K"
ticker: "EDSA"
cik: "0001540159"
company_name: "Edesa Biotech, Inc."
filed_at: "2024-10-31T23:59:59+00:00"
generated_at: "2026-05-30T07:24:53.532939+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Edesa Biotech enters $5M securities purchase agreement with CEO; $1.54M immediate investment

## Summary
- CEO-affiliated entity invests $1,540,819 for 150 Series A-1 Preferred Shares ($10K stated value) and warrants at $3.445 conversion/exercise price.
- Preferred shares convertible into 435,414 common shares; warrants cover 326,560 common shares (75% of conversion shares).
- Up to $5M total investment possible; purchases over $2M require shareholder approval under Canadian law.
- $10M revolving credit facility with same entity terminated; no funds drawn and no termination penalties.
- Securities issued in private placement exempt from registration; subject to Canadian hold periods.

## SEC filing metadata
- accession: 0001171843-24-005928
- form_type: 8-K
- ticker: EDSA
- cik: 0001540159
- company_name: Edesa Biotech, Inc.
- filed_at: 2024-10-31T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 5.03, 1.02, 2.03, 3.02, 3.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1540159/000117184324005928/0001171843-24-005928-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1540159/000117184324005928/f8k_103024.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-24-005928
- JSON: https://secwatch.observer/filing/0001171843-24-005928.json
- Plain text: https://secwatch.observer/filing/0001171843-24-005928.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.